跳至主要内容
临床试验/NCT04704869
NCT04704869已完成3 期

A Multi-center, Randomized, Controlled Trial Evaluating the Effects of Early High-Dose Cryoprecipitate in Adult Patients With Major Trauma Hemorrhage Requiring Major Hemorrhage Protocol (MHP) Activation

Bryan Cotton25 个研究点 分布在 2 个国家目标入组 1,604 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
1,604
试验地点
25
主要终点
Number of Participants With Mortality From Any Cause

研究概览

简要总结

The purpose of this trial is to compare standard of care (SOC) massive transfusion protocol to SOC massive transfusion protocol plus early use of cryoprecipitate (within 90 minutes of emergency department arrival).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient is judged to be an adult (according to local practice, e.g. 16 years or older in UK) and has sustained severe traumatic injury. In the event the age is unknown, estimated body weight ≥50 kg.
  • The patient is deemed by the attending clinician to have on-going active hemorrhage AND REQUIRES Activation of the local major hemorrhage protocol for management of severe blood loss AND HAS STARTED or HAS RECEIVED at least one unit of any blood component

排除标准

  • The patient has been transferred from another hospital
  • The trauma team leader deems the injuries incompatible with life
  • More than 3 hours have elapsed from the time of injury
  • Prisoner (as defined as someone admitted from a correctional facility)
  • Known "Do Not Resuscitate" orders
  • Enrolled in a concurrent ongoing interventional, randomized clinical trial
  • Patients who wear "opt out" bracelet for study
  • Obvious pregnancy
  • Severely burned

研究组 & 干预措施

Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Experimental

Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).

干预措施: Cryoprecipitate (Biological)

Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Experimental

Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).

干预措施: Red Blood Cells (Biological)

Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Experimental

Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).

干预措施: Plasma (Biological)

Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Experimental

Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).

干预措施: Platelets (Biological)

Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Experimental

Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).

干预措施: Whole Blood (Biological)

Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Active Comparator

Only standard of care massive transfusion protocol products will be given, including red blood cells, plasma, platelets, and whole blood.

干预措施: Red Blood Cells (Biological)

Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Active Comparator

Only standard of care massive transfusion protocol products will be given, including red blood cells, plasma, platelets, and whole blood.

干预措施: Plasma (Biological)

Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Active Comparator

Only standard of care massive transfusion protocol products will be given, including red blood cells, plasma, platelets, and whole blood.

干预措施: Platelets (Biological)

Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)

Active Comparator

Only standard of care massive transfusion protocol products will be given, including red blood cells, plasma, platelets, and whole blood.

干预措施: Whole Blood (Biological)

结局指标

主要结局

Number of Participants With Mortality From Any Cause

时间窗: 28 days after emergency department (ED) admission

Mortality from any cause

次要结局

  • All Cause Mortality at 6 Hours(6 hours after ED admission)
  • Death From Bleeding at 6 Hours(6 hours after ED admission)
  • Death From Bleeding at 24 Hours(24 hours after ED admission)
  • All Cause Mortality at 24 Hours(24 hours after ED admission)
  • All Cause Mortality at 6 Months(6 months after ED admission)
  • Quality of Life as Assessed by the Glasgow Outcome Score(6 months after ED admission)
  • Hospital Resource Use as Assessed by Number of Ventilator Days(Day of hospital discharge or 28 days after ED admission (whichever comes first))
  • Hospital Resource Use as Assessed by Number of Intensive Care Unit (ICU) Days(Day of hospital discharge or 28 days after ED admission (whichever comes first))
  • All Cause Mortality at 12 Months(12 months after ED admission)
  • Transfusion Requirements (Number of Units of Red Blood Cells (RBCs))(from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours)
  • Transfusion Requirements (Number of Units of Platelets)(from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours)
  • Transfusion Requirements (Number of Units of Cryoprecipitate)(from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours)
  • Hospital Resource Use as Assessed by Number of Hospital Days(Day of hospital discharge or 28 days after ED admission (whichever comes first))
  • Transfusion Requirements (Number of Units of Plasma)(from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours)
  • Destination of Participant at Time of Discharge From Hospital(at the time of discharge from hospital, about 11-27 days after admission)
  • Quality of Life as Assessed by EuroQol-5 Dimension-5 Level (EQ5D-5L)(6 months after ED admission)

研究者

发起方
Bryan Cotton
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Bryan Cotton

Professor of Surgery

The University of Texas Health Science Center, Houston

研究点 (25)

Loading locations...

相似试验